Cargando…
Engineered Platforms for Maturing Pluripotent Stem Cell–Derived Liver Cells for Disease Modeling
Several liver diseases (eg, hepatitis B/C viruses, alcoholic/nonalcoholic fatty liver, malaria, monogenic diseases, and drug-induced liver injury) significantly impact global mortality and morbidity. Species-specific differences in liver functions limit the use of animals to fully elucidate/predict...
Autores principales: | Yuan, Yang, Cotton, Kristen, Samarasekera, Dinithi, Khetani, Salman R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034210/ https://www.ncbi.nlm.nih.gov/pubmed/36738860 http://dx.doi.org/10.1016/j.jcmgh.2023.01.013 |
Ejemplares similares
-
Pluripotent Stem Cell-Derived Human Tissue: Platforms to Evaluate Drug Metabolism and Safety
por: Meseguer-Ripolles, Jose, et al.
Publicado: (2017) -
Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues
por: Shadrin, Ilya Y., et al.
Publicado: (2017) -
Latest impact of engineered human liver platforms on drug development
por: Monckton, Chase P., et al.
Publicado: (2021) -
Engineered Maturation Approaches of Human Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes
por: Ge, Feixiang, et al.
Publicado: (2019) -
Biowire: a new platform for maturation of human pluripotent stem cell derived cardiomyocytes
por: Nunes, Sara S., et al.
Publicado: (2013)